“…Regarding production practices, consumers are generally willing to pay a premium for organic or nongenetically modified products as well as reduced use of hormones and antibiotics compared to some conventional practices or no given information (Ding, Veeman, & Adamowicz, ; Lim et al, ; Miller et al, ; Ortega et al, ; Probst et al, ; Wu et al, ; Zanoli et al, ). Recently, these practices have also considered nanotechnology (Erdem, ; Yue, Zhao, & Kuzma, ). Preferences differ by consumer segmentation including purchase habits, product types, socio‐demographics (e.g., Arnoult, Lobb, & Tiffin, ; Van Loo, Caputo, Nayga, Meullenet, & Ricke, ), and concerns over production practices (Chung, Briggeman, & Han, ).…”